توقعات سوق تقنيات حاجز الدم في الدماغ في أوروبا حتى عام 2028 - تأثير فيروس كورونا (COVID-19) والتحليل الإقليمي بواسطة التكنولوجيا (نهج RMT للأجسام المضادة ثنائية النوعية، ونهج حصان طروادة، وزيادة النفاذية، والانتشار السلبي، وتقنيات BBB غير الغازية الأخرى) والتطبيق (مرض الزهايمر) (المرض، الصرع، مرض باركنسون، التصلب المتعدد، متلازمة هنتر، سرطان الدماغ، وغيرها)

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Blood Brain Barrier Technologies Market – By Technology

1.3.2        Europe Blood Brain Barrier Technologies Market – By Application

1.3.3        Europe Blood Brain Barrier Technologies Market– By Country

2.           Europe Blood Brain Barrier Technologies Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Blood Brain Barrier Technologies Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Europe Blood Brain Barrier Technologies Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Up-surging Prevalence of Neurological Disorders

5.1.2        Raising Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders

5.2         Market Restraints

5.2.1        Problems in Brain Medication Delivery

5.3         Market Opportunities

5.3.1        High Number of Product Approvals and Launches

5.4         Future Trends

5.4.1        Scaling Demand of Nanoparticles for Brain Drug Delivery

5.5         Impact Analysis

6.           Europe Blood Brain Barrier Technologies – Market Analysis

6.1         Europe Blood Brain Barrier Technologies Market Revenue Forecast and Analysis

7.           Europe Blood Brain Barrier Technologies Market Analysis – by Technology

7.1         Overview

7.2         Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)

7.3         Bispecific Antibody RMT Approach

7.3.1        Overview

7.3.2        Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Trojan Horse Approach

7.4.1        Overview

7.4.2        Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Increasing Permeability

7.5.1        Overview

7.5.2        Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Passive Diffusion

7.6.1        Overview

7.6.2        Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Other Non-Invasive BBB Technologies

7.7.1        Overview

7.7.2        Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Blood Brain Barrier Technologies Market Analysis – By Application

8.1         Overview

8.2         Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)

8.3         Alzheimer’s Disease

8.3.1        Overview

8.3.2        Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Epilepsy

8.4.1        Overview

8.4.2        Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Parkinson’s Disease

8.5.1        Overview

8.5.2        Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Multiple Sclerosis

8.6.1        Overview

8.6.2        Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Hunter’s Syndrome

8.7.1        Overview

8.7.2        Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Brain Cancer

8.8.1        Overview

8.8.2        Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.9         Others

8.9.1        Overview

8.9.2        Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Blood Brain Barrier Technologies Market – Country Analysis

9.1         Overview

9.1.1        Europe: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028(%)

9.1.1.1          Germany: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.1          Germany: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.2          Germany: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.1.1.1.3          Germany: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.2          France: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.1          France: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.2          France: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.1.1.2.3          France: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.3          UK: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.1          UK: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.2          UK: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.1.1.3.3          UK: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.4          Italy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.1          Italy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.2          Italy: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.1.1.4.3          Italy: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.5          Spain: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.5.1          Spain: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.5.2          Spain: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.1.1.5.3          Spain: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.6          Rest of Europe: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.6.1          Rest of Europe: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.6.2          Rest of Europe: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.1.1.6.3          Rest of Europe: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on Europe Blood Brain Barrier Technologies Market

10.1      Impact Assessment of COVID-19 Pandemic

11.        Europe Blood Brain Barrier Technologies Market– Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Teva Pharmaceutical Industries Ltd.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      F. Hoffmann-La Roche Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Eli Lilly and Company

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Bristol-Myers Squibb Company

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Pfizer, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Johnson and Johnson Services, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Fabre-Kramer Pharmaceuticals, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Bioasis Technologies, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Abliva AB.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Blood Brain Barrier Technologies Market – Revenue, and Forecast to 2028 (US$ Million)

Table 2.             Germany: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             France: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 5.             France: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6.             UK: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 7.             UK: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             Italy: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 9.             Italy: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.          Spain: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 11.          Spain: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of Europe: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of Europe: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 14.          Organic Developments Done By Companies

Table 15.          Inorganic Developments Done By Companies

Table 16.          Glossary of Terms, Blood Brain Barrier Technologies Market

LIST OF FIGURES

Figure 1.           Europe Blood Brain Barrier Technologies Market Segmentation

Figure 2.           Europe Blood Brain Barrier Technologies Market Segmentation, By Country

Figure 3.           Europe Blood Brain Barrier Technologies Market Overview

Figure 4.           Increasing Permeability Segment Held the Largest Share by Technology in Blood Brain Barrier Technologies Market

Figure 5.           U.K. to Show Significant Growth During Forecast Period

Figure 6.           Europe Blood Brain Barrier Technologies Market, Industry Landscape

Figure 7.           Europe and PEST Analysis

Figure 8.           Europe Blood Brain Barrier Technologies Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 9.           Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)

Figure 10.        Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)

Figure 16.        Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Europe: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)

Figure 24.        Europe: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

Figure 25.        Germany: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        France: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        UK: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Italy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Spain: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Rest of Europe: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Impact of COVID-19 Pandemic in European Country Markets

1. Teva Pharmaceutical Industries Ltd.                                         
2. F. Hoffmann-La Roche Ltd                                                            
3. Eli Lilly and Company                                                                    
4. Bristol-Myers Squibb Company                                                    
5. Pfizer, Inc.                                                                                       
6. Johnson & Johnson Services, Inc.                                               
7. Fabre-Kramer Pharmaceuticals, Inc.                                          
8. Bioasis Technologies, Inc.
9. Abliva AB.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe blood brain barrier technologies market.                                      
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe blood brain barrier technologies market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the blood brain barrier technologies market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution